Clover Health Investments Corp (CLOV)
$2.41
0.18 (8.07%)
CLOV Stock Quote Delayed 30 Minutes
Is Clover Stock a Buy Right Now? Its 160% Revenue Growth Says Yes.
Off and on the price chart, CLOV stock is heading towards a better tomorrow and has much less to do with recent meme-driven news.
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
11.68M
Day's Range
$2.22 - $2.41
52-Week Range
$1.95 - $14.44
Dividend & Yield
N/A (N/A)
CLOV Stock Predictions, Articles, and Clover Health Investments Corp News
Surprising Global Optimism Could Help Clover Health Stock Recover
Due to the worrying geopolitical flashpoint, CLOV stock seemed far too risky. But an unexpected hero may change everything.
Is CLOV Stock a Buy at 52-Week Lows? 3 Analysts Weigh In on Clover Health.
Here's what some expert analysts think about Clover Health and CLOV stock amid the stock's impressive decline to new 52-week lows.
A Buyout May Be the Best Hope for Clover Health Now
The situation behind CLOV stock is spiraling from bad to worse. A sale of the company may be the only option to keep Clover Health running.
CLOV Stock Price Predictions: Why One Analyst See Clover Health Shares Hitting $7
Clover Health Investments (CLOV) stock is on the move Wednesday following a new price prediction from Cowen analyst Gary Taylor.
At Below $3 Clover Health Stock May Be Worth It as a Moonshot
With CLOV stock, it may be worth rolling the dice at today's prices.
Clover Health Stock Remains a High-Risk High-Reward Play
Both Clover Health's bear and bull cases are equally compelling, which makes CLOV stock a highly risky bet right now.
Membership Growth Is Making Clover Health a More Convincing Investment
You can hold CLOV stock in hopes of another Reddit run-up, but there are also positive data points to support a long-term investment.
Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision
CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players.
Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet
Clover Health has a billion dollar yearly book of sales. Selloffs have limits, and we will soon find out if CLOV stock is a dud or a stud.
CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low
Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.
The Two Faces of Clover Health
CTO Andrew Toy has a great tool in the Clover Assistant, which can cut the costs of treating chronic conditions among aging patients. But will he get a chance to deploy it?
The Steep Drop In Clover Health Stock Sets up an Entry Opportunity
Now that CLOV stock has lost considerable steam. Investors are looking for the company to consolidate and report positive earnings from here.
Clover Health Is Not the $2 Billion Stock to Buy for 2022
Clover Health's market cap dropped 74% in 2021. Heading into 2022, CLOV stock is not the $2 billion market cap to buy.
Clover Health: 3 Key Factors That Are Worrisome and 1 That Brings Hope
CLOV stock has underperformed in 2021, became a meme stock, and now has many risks and challenges to face to reach profitability.
As Clover Health Stock Gets Diluted, Stockholders Are Giving Up
CLOV stock continues to punish long-suffering shareholders as it losses value. The latest public offering at the low-ball price of $5.75 is another nail in the coffin.
